"Non-small-cell lung cancer patients carrying XRCC1 Arg194Arg FAS-1377GG and FASL-844T allele displayed completely no response to platinum based drugs whereas patients with XRCC1 194Trp allele had 68.8% response rate to platinum antineoplastic agents."xsd:string